Serum ferritin, iron and transferrin in women with thyrotoxic Graves' disease before and after methimazole treatment

Acta Physiol Pol. 1990 Nov-Dec;41(7):163-8.

Abstract

We investigated iron metabolism in 47 women with thyrotoxic Graves' disease. Serum iron, ferritin, transferrin, triiodothyronine and thyroxine concentrations were RIA measured before and after methimazole treatment when patients became euthyroid. The control group consisted of 52 healthy women. We noted that serum ferritin levels and the ferritin to transferrin ration were significantly lower while the iron to ferritin ratio was higher in patients before and after methimazole therapy. Iron concentration as well as the iron to transferrin and the iron to thyroid hormone ratios were decreased only before treatment.

MeSH terms

  • Adult
  • Female
  • Ferritins / blood*
  • Graves Disease / blood*
  • Graves Disease / drug therapy
  • Humans
  • Iron / blood*
  • Methimazole / pharmacology*
  • Methimazole / therapeutic use
  • Radioimmunoassay
  • Thyroxine / blood
  • Transferrin / analysis*
  • Triiodothyronine / blood

Substances

  • Transferrin
  • Triiodothyronine
  • Methimazole
  • Ferritins
  • Iron
  • Thyroxine